Severe acute respiratory syndrome and the liver.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

16 citing papers in PubMed.

1. Serum proteomics for the identification of biomarkers to flag predilection of COVID19 patients to various organ morbidities.Clinical proteomics · 2024
   Article
2. SARS-CoV-2 and the liver: clinical and immunological features in chronic liver disease.Gut · 2023
   Review
3. Magic bullets, magic shields, and antimicrobials in between.Pharmaceutical science advances · 2023
   Review
4. Changes in liver enzymes and association with prognosis in patients with COVID-19: a retrospective case-control study.The Journal of international medical research · 2022
   Article
5. Neuroprotective Drug Discovery From Phytochemicals and Metabolites for CNS Viral Infection: A Systems Biology Approach With Clinical and Imaging Validation.Frontiers in neuroscience · 2022
   Article
6. Neuropilin-1: A feasible link between liver pathologies and COVID-19.World journal of gastroenterology · 2021
   Review
7. COVID-19 and pulmonary fibrosis: therapeutics in clinical trials, repurposing, and potential development.Archives of pharmacal research · 2021
   Review
8. Progressive liver injury and increased mortality risk in COVID-19 patients: A retrospective cohort study in China.World journal of gastroenterology · 2021
   Observational
9. A High Percentage of Patients Recovered From COVID-19 but Discharged With Abnormal Liver Function Tests.Frontiers in physiology · 2021
   Article
10. Effect of liver injury on prognosis and treatment of hospitalized patients with COVID-19 pneumonia.Annals of translational medicine · 2021
    Article
11. Tetracycline and viruses: a possible treatment for COVID-19?Archives of virology · 2021
    Review
12. Potential Anti-COVID-19 Therapeutics that Block the Early Stage of the Viral Life Cycle: Structures, Mechanisms, and Clinical Trials.International journal of molecular sciences · 2020
    Review
13. COVID-19 and liver cancer clinical trials: Not everything is lost.Liver international : official journal of the International Association for the Study of the Liver · 2020
    Article
14. Therapeutic Potential for Tetracyclines in the Treatment of COVID-19.Pharmacotherapy · 2020
    Article
15. Positive association between severity of COVID-19 infection and liver damage: a systematic review and meta-analysis.Gastroenterology and hepatology from bed to bench · 2020
    Review
16. Overexpression of 7a, a protein specifically encoded by the severe acute respiratory syndrome coronavirus, induces apoptosis via a caspase-dependent pathway.Journal of virology · 2004
    Article

Corrections and comments

• Comment on
  SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases.2004

Authors and funding

4 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as